1. Home
  2. NBY

NBY

NovaBay Pharmaceuticals Inc.

Logo NovaBay Pharmaceuticals Inc.

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Founded: N/A Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 3.2M IPO Year: 2007
Target Price: N/A AVG Volume (30 days): 3.3M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.96 EPS Growth: N/A
52 Week Low/High: $0.08 - $1.95 Next Earning Date: 05-09-2024
Revenue: $14,726,000 Revenue Growth: 2.24%
Revenue Growth (this year): 10.45% Revenue Growth (next year): 33.96%

Share on Social Networks: